TrialBlood advances2021

Caloric and nutrient restriction to augment chemotherapy efficacy for acute lymphoblastic leukemia: the IDEAL trial.

Etan Orgel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.